by ComplianceQuest

Inspection Tracker

Tracker Overview Enforcement Themes Form 483s Warning Letters Inspections Recalls Investigators Companies Facilities

FDA Guidance Global Templates

Start with a Free ConsultationBook 30 minutes with a ComplianceQuest specialist.Book a Call

Sign In Create a Free Account

Big News: FDA is moving from MasterControl to ComplianceQuest.See Why

Search AgentQ/

Talk to a Specialist

Loading…

My DashboardInspection TrackerForm 483sHopkinton Drug, Inc.

Hopkinton Drug, Inc.

Form 483FOIA Uncovered

United StatesIssued November 10, 2020

View FDA's Record for This Firm

Source: Third-party index, not matched to FDA. This record came from a third-party Form 483 index rather than from FDA directly, and we have not been able to match it to a document or an inspection FDA publishes. It stays out of the default view for that reason.

Observations2

Issue DateNovember 10, 2020

StatusWarning Letter Issued

Related Inspections0

Establishment Details

Firm: Hopkinton Drug, Inc.
Location: United States
FEI Number: N/A
Issue Date: November 10, 2020
Country: United States

Inspection History

We hold no FDA inspection matched to this establishment.

Act on This Form 483

FDA Inspection ReadinessSee how your operations would hold up to the same scrutiny.CAPA & InvestigationsScore how you would investigate and close findings like these.Talk to a SpecialistWalk through these observations with a ComplianceQuest expert.

Hopkinton Drug, Inc. FDA Form 483, November 10, 2020